Literature DB >> 32100472

Cutaneous findings of familial cerebral cavernous malformation syndrome due to the common Hispanic mutation.

Athanasios K Manole1, Vernon J Forrester2, Barrett J Zlotoff2, Blaine L Hart3, Leslie A Morrison4.   

Abstract

Familial cerebral cavernous malformations due to the common Hispanic mutation (FCCM1-CHM) is an endemic condition among the Hispanic population of the Southwestern United States associated with significant morbidity and mortality. Cutaneous vascular malformations (CVMs) can be found in individuals with FCCM1-CHM, but their morphology, prevalence, and association with cerebral cavernous malformations (CCMs) has not been well characterized. A cross-sectional study of 140 individuals with confirmed FCCM1-CHM was performed with statistical analyses of CVM, CCM, and patient characteristics. We then compared these findings to other cohorts with Familial cerebral cavernous malformations (FCCM) due to other mutations. We observed a higher overall prevalence and a different predominant morphological subtype of CVM compared to previous FCCM cohorts. While the number of CVMs was not a reliable indicator of the number of CCMs present, each person with one or more CVMs had evidence of central nervous system (CNS) disease. Awareness of the morphology of these cutaneous lesions can aid in the diagnosis of individuals with FCCM-CHM in Hispanic patients or those with family history of CCM.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990KRIT1 mutation; cerebral cavernous malformations; cutaneous vascular malformations; familial cerebral cavernous malformations

Mesh:

Substances:

Year:  2020        PMID: 32100472      PMCID: PMC8208466          DOI: 10.1002/ajmg.a.61519

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  22 in total

1.  Familial Cerebral Cavernous Malformations Are Associated with Adrenal Calcifications on CT Scans: An Imaging Biomarker for a Hereditary Cerebrovascular Condition.

Authors:  Corinne D Strickland; Steven C Eberhardt; Mary R Bartlett; Jeffrey Nelson; Helen Kim; Leslie A Morrison; Blaine L Hart
Journal:  Radiology       Date:  2017-03-20       Impact factor: 11.105

2.  Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1).

Authors:  T Sahoo; E W Johnson; J W Thomas; P M Kuehl; T L Jones; C G Dokken; J W Touchman; C J Gallione; S Q Lee-Lin; B Kosofsky; J H Kurth; D N Louis; G Mettler; L Morrison; A Gil-Nagel; S S Rich; J M Zabramski; M S Boguski; E D Green; D A Marchuk
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

3.  Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas.

Authors:  S Laberge-le Couteulx; H H Jung; P Labauge; J P Houtteville; C Lescoat; M Cecillon; E Marechal; A Joutel; J F Bach; E Tournier-Lasserve
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

4.  Identification of a c.601C>G mutation in the CCM1 gene in a kindred with multiple skin, spinal and cerebral cavernous malformations.

Authors:  Alireza Haghighi; Davood Fathi; Majid Shahbazi; Mohammad-Mahdy Motahari; Bethany Friedman
Journal:  J Neurol Sci       Date:  2013-08-07       Impact factor: 3.181

Review 5.  Molecular genetics of vascular malformations.

Authors:  M Vikkula; L M Boon; J B Mulliken
Journal:  Matrix Biol       Date:  2001-09       Impact factor: 11.583

6.  KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation.

Authors:  I Eerola; K H Plate; R Spiegel; L M Boon; J B Mulliken; M Vikkula
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

7.  Familial cerebral cavernous angiomas: clinical and radiologic studies.

Authors:  V J Kattapong; B L Hart; L E Davis
Journal:  Neurology       Date:  1995-03       Impact factor: 9.910

Review 8.  Neurofibromatosis type 1.

Authors:  Kevin P Boyd; Bruce R Korf; Amy Theos
Journal:  J Am Acad Dermatol       Date:  2009-07       Impact factor: 11.527

Review 9.  Tuberous sclerosis complex: advances in diagnosis, genetics, and management.

Authors:  Robert A Schwartz; Geover Fernández; Katarzyna Kotulska; Sergiusz Jóźwiak
Journal:  J Am Acad Dermatol       Date:  2007-08       Impact factor: 11.527

10.  Brain Vascular Malformation Consortium: Overview, Progress and Future Directions.

Authors:  Amy L Akers; Karen L Ball; Marianne Clancy; Anne M Comi; Marie E Faughnan; Rashmi Gopal-Srivastava; Thomas P Jacobs; Helen Kim; Jeffrey Krischer; Douglas A Marchuk; Charles E McCulloch; Leslie Morrison; Marsha Moses; Claudia S Moy; Ludmilla Pawlikowska; William L Young
Journal:  J Rare Disord       Date:  2013-04-01
View more
  3 in total

1.  Natural history of familial cerebral cavernous malformation syndrome in children: a multicenter cohort study.

Authors:  Ana Filipa Geraldo; Cesar Augusto P F Alves; Aysha Luis; Domenico Tortora; Joana Guimarães; Daisy Abreu; Sofia Reimão; Marco Pavanello; Patrizia de Marco; Marcello Scala; Valeria Capra; Rui Vaz; Andrea Rossi; Erin Simon Schwartz; Kshitij Mankad; Mariasavina Severino
Journal:  Neuroradiology       Date:  2022-10-06       Impact factor: 2.995

Review 2.  Systemic and CNS manifestations of inherited cerebrovascular malformations.

Authors:  Blaine L Hart; Marc C Mabray; Leslie Morrison; Kevin J Whitehead; Helen Kim
Journal:  Clin Imaging       Date:  2021-01-20       Impact factor: 2.420

3.  Assessing the association of common genetic variants in EPHB4 and RASA1 with phenotype severity in familial cerebral cavernous malformation.

Authors:  Foram Choksi; Shantel Weinsheimer; Jeffrey Nelson; Ludmila Pawlikowska; Christine K Fox; Atif Zafar; Marc C Mabray; Joseph Zabramski; Amy Akers; Blaine L Hart; Leslie Morrison; Charles E McCulloch; Helen Kim
Journal:  Mol Genet Genomic Med       Date:  2021-09-07       Impact factor: 2.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.